Sai Life Sciences will debut on the exchanges on Wednesday. Ahead of the listing, the company's shares were trading with a GMP of Rs 72 in the unlisted market.
Considering the upper price band of Rs 549, the stock is expected to see a premium of just over 13% on listing.
However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly.
Sai Life Sciences IPO received decent demand from all sets of investor’s especially from institutional investors, while retail and NII remained less interested due to expensive valuations along with high portions of OFS in the offer.
«Considering improving market sentiments and all other parameters the company can list with a very decent listing gain around 10% to its issue price,» said Prashanth Tapse, Sr VP Research – Research Analyst, Mehta Equities.
Stock Trading
RSI Trading Techniques: Mastering the RSI Indicator
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Macroeconomics Made Easy: Online Certification Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Options Trading Course For Beginners
By — Chetan Panchamia, Options Trader
Stock Trading
A2Z of Stock Trading — Online Stock Trading Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock